Should aspirin therapy be withheld before insertion and/or removal of a permanent peritoneal dialysis catheter?

American Surgeon

Volumn 68, Issue 9, 2002, Pages 762-764

  Shpitz, Baruch ^a   Plotkin, Eleanora ^a,b   Spindel, Zvi ^a   Buklan, Genadi ^a   Klein, Ehud ^a   Bernheim, Jacques ^a,b   Korzets, Ze'ev ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

AGED; ARTICLE; CATHETER REMOVAL; CATHETERIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; HUMAN; KIDNEY FAILURE; LOCAL ANESTHESIA; MALE; PERITONEAL DIALYSIS; PERITONITIS; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; SURGICAL TECHNIQUE; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; INDWELLING CATHETER; PROSPECTIVE STUDY;

AGED; ASPIRIN; CASE-CONTROL STUDIES; CATHETERS, INDWELLING; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PERITONEAL DIALYSIS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES;

EID: 0036728657     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rao GH, White JG. Comparative pharmacology of cyclooxygenase inhibitors on platelet function. Prostaglandins Leukot Med 1985;18:119-31.
2. Meier PJ, Oelz O. Aspirin as a platelet inhibitor. Pharmakritik Int 1990;1:1-4.
3. Gay WA. Aspirin, blood loss and transfusion. Ann Thorac Surg 1990;50:345.
4. Ferraris VA, Ferraris SP, Lough FC, et al. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Ann Thorac Surg 1988;45:71-4.
5. Sethi GK, Copeland JG, Goldman S, et al. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 1990;15:15-20.
6. Watson CJE, Deane ME, Doyle PT, et al. Identifiable factors in past-prostatectomy hemorrhage: The role of aspirin. Br J Urol 1990;66:85-7.
7. Thurston AV, Briant SL. Aspirin and post prostatectomy haemorrhage. Br J Urol 1993;71:574-6.
8. Wierod FS, Frandsen NJ, Jacobsen JD, et al. Risk of haemorrhage from transurethral prostatectomy in acetylsalicylic acid and NSAID treated patients. Scand J Urol Nephrol 1998;32:120-2.
9. Shuler JD, Paschal JF, Hollard GN. Antiplatelet therapy and cataract surgery. J Cataract Refract Surg 1992;18:567-71.
10. Connelly CS, Panush RS. Should non-steroidal antiinflammatory drugs be stopped before elective surgery? Arch Intern Med 1991;151:1963-6.
11. Otley CC, Fewkes JL, Frank W, et al. Complications of cutaneous surgery in patients who are taking warfarin, aspirin or non-steroidal antiinflammatory drugs. Arch Dermatol 1996;132:161-6.
12. Bartlett GR. Does aspirin affect the outcome of minor cutaneous surgery? Br J Plastic Surg 1999;52:214-6.
13. Steiner RW, Coggins C, Carvalho AC. Bleeding time in uremia: A useful test to assess clinical bleeding. Am J Hematol 1979;2:107-17.
14. Levey AS. Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start? Am J Kidney Dis 1998;32(Suppl 3):S5-13.
15. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
16. Gaspari F, Vigano G, Orisio S, et al. Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition. J Clin Invest 1987;79:1788-97.
17. De Caterina R, Lanza M, Manca G, et al. Bleeding time and bleeding: An analysis of the relationship of the bleeding time with parameters of surgical bleeding. Blood 1994;84:3363-70.
18. Lind SE. The bleeding time does not predict surgical bleeding. Blood 1991;77:2547-52.
19. Schafer AI. Effects of nonsteroidal anti inflammatory therapy on platelets. Am J Med 1999;106:25S-36S.